US Stock MarketDetailed Quotes

OCX OncoCyte

Watchlist
  • 2.9000
  • -0.1000-3.33%
Close Nov 4 16:00 ET
  • 2.9000
  • 0.00000.00%
Post 20:01 ET
48.82MMarket Cap-683P/E (TTM)

OncoCyte Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
12.50%-5.98M
53.86%-3.83M
48.81%-23.33M
52.72%-4.56M
68.14%-3.63M
39.25%-6.83M
37.49%-8.3M
-26.79%-45.57M
-36.56%-9.65M
-3.76%-11.4M
Net income from continuing operations
45.64%-4.53M
-400.99%-9.13M
61.89%-27.78M
64.44%-15.99M
30.47%-6.49M
-0.40%-8.33M
129.47%3.03M
-13.74%-72.9M
-25.34%-44.98M
32.37%-9.33M
Operating gains losses
----
----
185.35%1.34M
--61K
----
----
----
154.08%471K
----
----
Depreciation and amortization
-28.67%326K
-29.03%335K
-67.82%1.68M
-74.57%325K
-68.84%426K
-66.40%457K
-61.15%472K
24.14%5.22M
2.08%1.28M
9.80%1.37M
Other non cash items
-157.44%-1.03M
119.73%3.31M
86.32%-4.24M
180.97%10.94M
96.95%-189K
126.95%1.8M
-261.07%-16.79M
-213.49%-31.01M
-154.01%-13.51M
-638.09%-6.19M
Change In working capital
26.72%-1.18M
151.86%1.02M
-104.48%-3.97M
-225.31%-510K
119.38%113K
-1,376.98%-1.61M
-3.86%-1.97M
-1,403.36%-1.94M
-44.32%407K
-165.80%-583K
-Change in receivables
-58.92%76K
190.99%323K
118.96%109K
4.55%-21K
11.70%-166K
-42.19%185K
116.20%111K
53.21%-575K
94.57%-22K
-2,585.71%-188K
-Change in prepaid assets
123.08%12K
-110.02%-62K
439.39%784K
--0
675.00%217K
87.68%-52K
276.35%619K
-201.76%-231K
-49.31%514K
104.09%28K
-Change in payables and accrued expense
25.17%-1.24M
132.08%854K
-366.37%-4.76M
60.89%-564K
-31.15%126K
-737.31%-1.66M
-12,576.19%-2.66M
24.33%-1.02M
-690.98%-1.44M
122.15%183K
-Change in other current assets
----
----
----
----
----
----
----
----
----
--0
-Change in other working capital
----
-190.91%-96K
7.76%-107K
-104.72%-64K
----
----
95.88%-33K
-104.93%-116K
1,457.00%1.36M
---656K
Cash from discontinued investing activities
Operating cash flow
12.50%-5.98M
53.86%-3.83M
48.81%-23.33M
52.72%-4.56M
68.14%-3.63M
39.25%-6.83M
37.49%-8.3M
-26.79%-45.57M
-36.56%-9.65M
-3.76%-11.4M
Investing cash flow
Cash flow from continuing investing activities
-255.28%-191K
-24K
110.14%440K
112.84%103K
124.91%214K
111.00%123K
0
68.91%-4.34M
-100.00%-802K
-118.02%-859K
Net PPE purchase and sale
-255.28%-191K
---24K
101.68%73K
67.08%-264K
124.91%214K
111.00%123K
--0
-93.15%-4.34M
-100.00%-802K
-118.02%-859K
Net investment purchase and sale
----
----
--367K
----
----
----
----
--0
----
----
Cash from discontinued investing activities
Investing cash flow
-255.28%-191K
98.25%-24K
78.53%-932K
130.05%241K
108.85%76K
111.00%123K
12.11%-1.37M
68.91%-4.34M
-100.00%-802K
-118.02%-859K
Financing cash flow
Cash flow from continuing financing activities
-19.77%9.85M
0
-65.97%12.19M
70.00%-30K
94.32%-30K
-66.64%12.27M
92.11%-28K
-54.31%35.81M
62.83%-100K
-106.43%-528K
Net issuance payments of debt
-13.79%-33K
--0
91.81%-117K
70.00%-30K
94.32%-30K
93.03%-29K
92.73%-28K
6.84%-1.43M
64.54%-100K
-26.32%-528K
Net common stock issuance
----
----
-57.84%13.85M
--0
--0
----
----
-57.76%32.84M
--0
--0
Net preferred stock issuance
----
----
-122.93%-1.12M
--0
--0
----
----
--4.88M
--0
--0
Net other financing activities
----
----
11.59%-427K
--0
--0
----
----
84.24%-483K
--0
--0
Cash from discontinued financing activities
Financing cash flow
-19.77%9.85M
--0
-65.97%12.19M
70.00%-30K
94.32%-30K
-66.64%12.27M
92.11%-28K
-54.31%35.81M
62.83%-100K
-106.43%-528K
Net cash flow
Beginning cash position
-46.10%7.28M
-52.02%11.13M
-37.80%23.2M
-54.13%15.48M
-59.03%19.07M
-38.88%13.5M
-37.80%23.2M
321.86%37.31M
-25.06%33.75M
-3.46%46.54M
Current changes in cash
-33.91%3.68M
60.27%-3.85M
14.40%-12.07M
58.76%-4.35M
71.95%-3.59M
-77.23%5.57M
36.24%-9.7M
-149.55%-14.1M
-36.39%-10.55M
-304.27%-12.78M
End cash Position
-42.54%10.96M
-46.10%7.28M
-52.02%11.13M
-52.02%11.13M
-54.13%15.48M
-59.03%19.07M
-38.88%13.5M
-37.80%23.2M
-37.80%23.2M
-25.06%33.75M
Free cash flow
9.70%-6.17M
53.57%-3.85M
52.70%-23.61M
53.82%-4.83M
70.23%-3.65M
44.75%-6.83M
44.06%-8.3M
-30.69%-49.91M
-39.97%-10.45M
-7.72%-12.26M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 12.50%-5.98M53.86%-3.83M48.81%-23.33M52.72%-4.56M68.14%-3.63M39.25%-6.83M37.49%-8.3M-26.79%-45.57M-36.56%-9.65M-3.76%-11.4M
Net income from continuing operations 45.64%-4.53M-400.99%-9.13M61.89%-27.78M64.44%-15.99M30.47%-6.49M-0.40%-8.33M129.47%3.03M-13.74%-72.9M-25.34%-44.98M32.37%-9.33M
Operating gains losses --------185.35%1.34M--61K------------154.08%471K--------
Depreciation and amortization -28.67%326K-29.03%335K-67.82%1.68M-74.57%325K-68.84%426K-66.40%457K-61.15%472K24.14%5.22M2.08%1.28M9.80%1.37M
Other non cash items -157.44%-1.03M119.73%3.31M86.32%-4.24M180.97%10.94M96.95%-189K126.95%1.8M-261.07%-16.79M-213.49%-31.01M-154.01%-13.51M-638.09%-6.19M
Change In working capital 26.72%-1.18M151.86%1.02M-104.48%-3.97M-225.31%-510K119.38%113K-1,376.98%-1.61M-3.86%-1.97M-1,403.36%-1.94M-44.32%407K-165.80%-583K
-Change in receivables -58.92%76K190.99%323K118.96%109K4.55%-21K11.70%-166K-42.19%185K116.20%111K53.21%-575K94.57%-22K-2,585.71%-188K
-Change in prepaid assets 123.08%12K-110.02%-62K439.39%784K--0675.00%217K87.68%-52K276.35%619K-201.76%-231K-49.31%514K104.09%28K
-Change in payables and accrued expense 25.17%-1.24M132.08%854K-366.37%-4.76M60.89%-564K-31.15%126K-737.31%-1.66M-12,576.19%-2.66M24.33%-1.02M-690.98%-1.44M122.15%183K
-Change in other current assets --------------------------------------0
-Change in other working capital -----190.91%-96K7.76%-107K-104.72%-64K--------95.88%-33K-104.93%-116K1,457.00%1.36M---656K
Cash from discontinued investing activities
Operating cash flow 12.50%-5.98M53.86%-3.83M48.81%-23.33M52.72%-4.56M68.14%-3.63M39.25%-6.83M37.49%-8.3M-26.79%-45.57M-36.56%-9.65M-3.76%-11.4M
Investing cash flow
Cash flow from continuing investing activities -255.28%-191K-24K110.14%440K112.84%103K124.91%214K111.00%123K068.91%-4.34M-100.00%-802K-118.02%-859K
Net PPE purchase and sale -255.28%-191K---24K101.68%73K67.08%-264K124.91%214K111.00%123K--0-93.15%-4.34M-100.00%-802K-118.02%-859K
Net investment purchase and sale ----------367K------------------0--------
Cash from discontinued investing activities
Investing cash flow -255.28%-191K98.25%-24K78.53%-932K130.05%241K108.85%76K111.00%123K12.11%-1.37M68.91%-4.34M-100.00%-802K-118.02%-859K
Financing cash flow
Cash flow from continuing financing activities -19.77%9.85M0-65.97%12.19M70.00%-30K94.32%-30K-66.64%12.27M92.11%-28K-54.31%35.81M62.83%-100K-106.43%-528K
Net issuance payments of debt -13.79%-33K--091.81%-117K70.00%-30K94.32%-30K93.03%-29K92.73%-28K6.84%-1.43M64.54%-100K-26.32%-528K
Net common stock issuance ---------57.84%13.85M--0--0---------57.76%32.84M--0--0
Net preferred stock issuance ---------122.93%-1.12M--0--0----------4.88M--0--0
Net other financing activities --------11.59%-427K--0--0--------84.24%-483K--0--0
Cash from discontinued financing activities
Financing cash flow -19.77%9.85M--0-65.97%12.19M70.00%-30K94.32%-30K-66.64%12.27M92.11%-28K-54.31%35.81M62.83%-100K-106.43%-528K
Net cash flow
Beginning cash position -46.10%7.28M-52.02%11.13M-37.80%23.2M-54.13%15.48M-59.03%19.07M-38.88%13.5M-37.80%23.2M321.86%37.31M-25.06%33.75M-3.46%46.54M
Current changes in cash -33.91%3.68M60.27%-3.85M14.40%-12.07M58.76%-4.35M71.95%-3.59M-77.23%5.57M36.24%-9.7M-149.55%-14.1M-36.39%-10.55M-304.27%-12.78M
End cash Position -42.54%10.96M-46.10%7.28M-52.02%11.13M-52.02%11.13M-54.13%15.48M-59.03%19.07M-38.88%13.5M-37.80%23.2M-37.80%23.2M-25.06%33.75M
Free cash flow 9.70%-6.17M53.57%-3.85M52.70%-23.61M53.82%-4.83M70.23%-3.65M44.75%-6.83M44.06%-8.3M-30.69%-49.91M-39.97%-10.45M-7.72%-12.26M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --------------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data